Your browser doesn't support javascript.
loading
Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma.
Shamseddine, Ali; Zeidan, Youssef H; El Husseini, Ziad; Kreidieh, Malek; Al Darazi, Monita; Turfa, Rim; Kattan, Joseph; Khalifeh, Ibrahim; Mukherji, Deborah; Temraz, Sally; Alqasem, Kholoud; Amarin, Rula; Al Awabdeh, Tala; Deeba, Samer; Jamali, Faek; Mohamad, Issa; Elkhaldi, Mousa; Daoud, Faiez; Al Masri, Mahmoud; Dabous, Ali; Hushki, Ahmad; Jaber, Omar; Charafeddine, Maya; Geara, Fady.
Afiliação
  • Shamseddine A; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon. as04@aub.edu.lb.
  • Zeidan YH; Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
  • El Husseini Z; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
  • Kreidieh M; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
  • Al Darazi M; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
  • Turfa R; Division of Hematology/Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Kattan J; Department of Hematology/Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon.
  • Khalifeh I; Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
  • Mukherji D; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
  • Temraz S; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
  • Alqasem K; Division of Hematology/Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Amarin R; Division of Hematology/Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Al Awabdeh T; Division of Hematology/Oncology, Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Deeba S; Division of General Surgery, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
  • Jamali F; Division of General Surgery, Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.
  • Mohamad I; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Elkhaldi M; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Daoud F; Department of Surgical Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Al Masri M; Department of Surgical Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Dabous A; Department of Surgical Oncology, King Hussein Cancer Center, Amman, Jordan.
  • Hushki A; Division of Gastroenterology, Department of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
  • Jaber O; Department of Pathology, King Hussein Cancer Center, Amman, Jordan.
  • Charafeddine M; Division of Hematology/Oncology, Department of Internal Medicine, Naef K. Basile Cancer Institute - NKBCI, American University of Beirut Medical Center, Beirut, Lebanon.
  • Geara F; Department of Radiation Oncology, American University of Beirut Medical Center, Beirut, Lebanon.
Radiat Oncol ; 15(1): 233, 2020 Oct 07.
Article em En | MEDLINE | ID: mdl-33028346

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiat Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Retais / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Anticorpos Monoclonais Humanizados / Antineoplásicos Imunológicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Radiat Oncol Ano de publicação: 2020 Tipo de documento: Article